Silencing eIF4E led to a strong repression of HSV1-dICP0 infection in cancer cells treated with asTORi, while silencing 4E-BP1 or 4E-BP2 had a reverse effect (Fig 6A and 6B and S4F Fig). The gene discussed is EIF4EBP1; the disease is cancer.